[关键词]
[摘要]
随着眼周美容操作的普及，注射填充、激光治疗、纹绣等操作引发的睑板腺功能障碍及其他睑板腺疾病日益增多，但其诊疗规范尚存争议。专家共识基于多学科临床经验及循证医学证据，系统梳理了美容操作相关性睑板腺疾病的发病机制、临床表现及诊断标准，强调病史采集与眼表综合分析的重要性，并提出阶梯化治疗方案：包括保守治疗、药物治疗及物理治疗。同时，共识规范了操作前评估要点，提倡术中规避腺体损伤、术后定期随访监测，以降低医源性风险。共识旨在提升临床医师对眼周美容相关性睑板腺功能障碍的认知与诊疗水平，促进美容安全性与眼表健康的平衡发展。
[Key word]
[Abstract]
With the growing popularity of periocular cosmetic procedures, including injectable fillers, laser therapy, and eyeliner tattooing, the incidence of meibomian gland dysfunction(MGD)and other meibomian gland disorders has increased correspondingly. Nevertheless, the standardized diagnosis and management of these conditions remain controversial. Based on multidisciplinary clinical practice and up-to-date evidence-based medical evidence, this expert consensus systematically elaborates on the pathogenesis, clinical manifestations, and diagnostic criteria of cosmetic procedure-related MGD. It highlights the necessity of detailed medical history collection and comprehensive ocular surface assessment. A stepwise therapeutic strategy, covering conservative nursing management, pharmacological intervention, and physical therapy, is proposed for standardized clinical treatment. In addition, this consensus standardizes the preoperative evaluation workflow for periocular cosmetic procedures, optimizes operational techniques to prevent meibomian gland injury, and stresses the significance of standardized postoperative follow-up for reducing iatrogenic ocular complications. This consensus intends to improve clinicians'cognition and standardized management of periocular cosmetic procedure-related MGD, and facilitate a benign balance between cosmetic procedural safety and ocular surface health.
[中图分类号]
[基金项目]
国家自然科学基金项目(No.82460203); 吉林省自然科学基金项目(No.YDZJ202401111ZYTS); 国家重点研发项目(No.2025YFA1212700,2025YFA1212702)
